CytomX Therapeutics Net Other Investing Changes (Quarterly) Analysis

CytomX Therapeutics, Inc. (CTMX)

5.44 -0.34 (-5.88%) USD | NASDAQ | Feb 26, 11:45

View Net Other Investing Changes (Quarterly) for CTMX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Other Investing Changes (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Other Investing Changes (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Other Investing Changes (Quarterly) Benchmarks

Start Trial

REGENXBIO, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--
Savara, Inc.	--
BioMarin Pharmaceutical, Inc.	--